Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Regul Toxicol Pharmacol ; 100: 52-58, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30359704

RESUMEN

2-hydroxybenzylamine (2-HOBA), a naturally occurring compound found in buckwheat, has potential for use as a nutrition supplement due to its ability to protect against the damaging effects of oxidative stress. In a series of rodent toxicity studies, 2-HOBA acetate was well-tolerated and did not produce any toxic effects over 28 or 90 days of repeated oral administration. However, it remained necessary to test the potential toxicity of 2-HOBA acetate in a non-rodent species. In this investigation, 2-HOBA acetate was orally administered to male and female New Zealand White Rabbits for 90 days at doses of 100, 500, and 1000 mg·kg BW-1·day-1 (n = 5 per sex/group). As previously observed in rodents, 2-HOBA acetate administration was well tolerated. No toxic effects of 2-HOBA acetate were detected in body weight, feed consumption, hematology, blood chemistry, urine chemistry, organ weights, gross pathology or histopathology. Based on these findings, the no-observed-adverse-effect-level of 2-HOBA acetate in rabbits was determined to be 1000 mg·kg BW-1·day-1, which was the highest dose tested. These results provide further support for the safety of 2-HOBA acetate administration.


Asunto(s)
Bencilaminas/toxicidad , Administración Oral , Animales , Suplementos Dietéticos , Femenino , Alimentos Funcionales , Masculino , Nivel sin Efectos Adversos Observados , Conejos , Pruebas de Toxicidad Subcrónica
2.
J Inorg Biochem ; 172: 9-15, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28414928

RESUMEN

Leishmaniasis is an infection caused by protozoa of the genus Leishmania and transmitted by sandflies. Current treatments are expensive and time-consuming, involving Sb(V)-based compounds, lipossomal amphotericin B and miltefosine. Recent studies suggest that inhibition of trypanothione reductase (TR) could be a specific target in the development of new drugs because it is essential and exclusive to trypanosomatids. This work presents the synthesis and characterization of new iminodibenzyl derivatives (dado) with ethylenediamine (ea), ethanolamine (en) and diethylenetriamine (dien) and their copper(II) complexes. Computational methods indicated that the complexes were highly lipophilic. Pro-oxidant activity assays by oxidation of the dihydrorhodamine (DHR) fluorimetric probe showed that [Cu(dado-ea)]2+ has the highest rate of oxidation, independent of H2O2 concentration. The toxicity to L. amazonensis promastigotes and RAW 264,7 macrophages was assessed, showing that dado-en was the most active new compound. Complexation to copper did not have an appreciable effect on the toxicity of the compounds.


Asunto(s)
Bencilaminas/química , Leishmania/efectos de los fármacos , Animales , Antiprotozoarios/síntesis química , Antiprotozoarios/química , Antiprotozoarios/farmacología , Antiprotozoarios/toxicidad , Bencilaminas/farmacología , Bencilaminas/toxicidad , Simulación por Computador , Cobre/química , Relación Dosis-Respuesta a Droga , Concentración 50 Inhibidora , Leishmania/enzimología , Ligandos , Macrófagos/efectos de los fármacos , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , Oxidación-Reducción
3.
J Med Chem ; 52(5): 1408-15, 2009 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-19222165

RESUMEN

N-tert-Butyl isoquine (4) (GSK369796) is a 4-aminoquinoline drug candidate selected and developed as part of a public-private partnership between academics at Liverpool, MMV, and GSK pharmaceuticals. This molecule was rationally designed based on chemical, toxicological, pharmacokinetic, and pharmacodynamic considerations and was selected based on excellent activity against Plasmodium falciparum in vitro and rodent malaria parasites in vivo. The optimized chemistry delivered this novel synthetic quinoline in a two-step procedure from cheap and readily available starting materials. The molecule has a full industry standard preclinical development program allowing first into humans to proceed. Employing chloroquine (1) and amodiaquine (2) as comparator molecules in the preclinical plan, the first preclinical dossier of pharmacokinetic, toxicity, and safety pharmacology has also been established for the 4-aminoquinoline antimalarial class. These studies have revealed preclinical liabilities that have never translated into the human experience. This has resulted in the availability of critical information to other drug development teams interested in developing antimalarials within this class.


Asunto(s)
Aminoquinolinas/farmacología , Antimaláricos/farmacología , Bencilaminas/farmacología , Aminoquinolinas/síntesis química , Aminoquinolinas/química , Aminoquinolinas/farmacocinética , Aminoquinolinas/toxicidad , Amodiaquina/análogos & derivados , Animales , Antimaláricos/síntesis química , Antimaláricos/farmacocinética , Antimaláricos/toxicidad , Bencilaminas/síntesis química , Bencilaminas/química , Bencilaminas/toxicidad , Inhibidores Enzimáticos del Citocromo P-450 , Perros , Evaluación Preclínica de Medicamentos , Resistencia a Medicamentos , Femenino , Haplorrinos , Hemo/química , Humanos , Malaria/tratamiento farmacológico , Ratones , Modelos Moleculares , Plasmodium berghei/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Plasmodium yoelii , Ratas , Relación Estructura-Actividad
4.
J Agric Food Chem ; 54(16): 5954-7, 2006 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-16881700

RESUMEN

N-(2-Bromophenyl)-2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamine is a highly active herbicide, which belongs to a novel class of chemistry. The compound is de novo synthesized in good yield, and the structure is confirmed by (1)H NMR, IR, MS, microanalysis, and X-ray. Its herbicidal activity is assessed under greenhouse conditions. It is effective against many grass weed species, as well as broadleaf weeds, under greenhouse conditions. Field trials indicate that it controls major weeds with a good tolerance on oilseed rape by postemergence application at rates of 15-90 g of active ingredient/ha. This compound possesses low mammalian toxicity and favorable environmental profile. These results suggest that the compound has potential as a new selective postemergent herbicide in winter oilseed rape.


Asunto(s)
Bencilaminas/farmacología , Brassica rapa/crecimiento & desarrollo , Herbicidas/farmacología , Pirimidinas/farmacología , Bencilaminas/toxicidad , Ácidos Grasos Monoinsaturados , Herbicidas/toxicidad , Aceites de Plantas , Poa/efectos de los fármacos , Poaceae/efectos de los fármacos , Pirimidinas/toxicidad , Aceite de Brassica napus , Estaciones del Año , Factores de Tiempo
5.
Eur J Neurosci ; 17(12): 2586-92, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12823465

RESUMEN

Parkinson's disease is characterized not only by a progressive loss of dopaminergic neurons in the substantia nigra but also by a degeneration of locus coeruleus noradrenergic neurons. The present study addresses the question of whether a partial neurodegeneration of dopaminergic neurons using 6-hydroxydopamine in rat, not sufficient to produce motor disturbances, is potentiated by prior selective denervation of locus coeruleus noradrenergic terminal fields using N-ethyl-2-bromobenzylamine. Two types of denervations, one causing dopamine deficiency alone and the other causing noradrenaline and dopamine deficiency, were performed. Noradrenaline, 5-hydroxytryptamine, 5-hydroxyindole acetic acid, dopamine and its metabolites were analysed in various brain regions. Behaviour was evaluated by catalepsy tests and activity box. N-ethyl-2-bromobenzylamine selectively depleted noradrenaline from neurons of locus coeruleus origin. Decreased dopamine content in the striatum, substantia nigra and pre-frontal cortex was observed after dopaminergic lesion with 6-hydroxydopamine (42.9%). Additional locus coeruleus noradrenaline depletion with N-ethyl-2-bromobenzylamine aggravated the dopamine depletion (61.2%). The lesion in the noradrenergic and dopaminergic neurodegenerated group was not sufficient to induce consistent catalepsy and akinesia. However, after a subthreshold dose of haloperidol (0.1 mg/kg), the expression of catalepsy and akinesia was strong in the dual-lesioned group and less in the 6-hydroxydopamine-lesioned group. These results indicate that denervation of locus coeruleus noradrenergic terminals with N-ethyl-2-bromobenzylamine potentiates the 6-hydroxydopamine-induced partial dopaminergic neurodegeneration and parkinsonian symptoms. Based on the present findings and existing reports, it can be concluded that noradrenergic neurons of locus coeruleus have neuromodulatory and neuroprotective properties on the dopaminergic neurons of basal ganglia and that noradrenergic degeneration may contribute to the aetiology and pathophysiology of Parkinson's disease.


Asunto(s)
Locus Coeruleus/metabolismo , Norepinefrina/metabolismo , Trastornos Parkinsonianos/metabolismo , Trastornos Parkinsonianos/fisiopatología , Sustancia Negra/fisiopatología , Tirosina/análogos & derivados , Ácido 3,4-Dihidroxifenilacético/análisis , Ácido 3,4-Dihidroxifenilacético/metabolismo , Adrenérgicos/toxicidad , Animales , Conducta Animal , Bencilaminas/toxicidad , Catalepsia/inducido químicamente , Catalepsia/metabolismo , Modelos Animales de Enfermedad , Dopamina/análisis , Dopamina/metabolismo , Antagonistas de Dopamina/farmacología , Interacciones Farmacológicas , Haloperidol/farmacología , Hipocampo/química , Hipocampo/metabolismo , Ácido Homovanílico/análisis , Ácido Homovanílico/metabolismo , Hipotálamo/química , Hipotálamo/metabolismo , Masculino , Haz Prosencefálico Medial/metabolismo , Haz Prosencefálico Medial/fisiopatología , Degeneración Nerviosa/metabolismo , Neurotoxinas/toxicidad , Norepinefrina/análisis , Oxidopamina/toxicidad , Corteza Prefrontal/química , Corteza Prefrontal/metabolismo , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Serotonina/análisis , Serotonina/metabolismo , Tálamo/química , Tálamo/metabolismo , Tirosina/análisis , Tirosina/metabolismo
6.
Eur Neuropsychopharmacol ; 13(1): 19-28, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12480118

RESUMEN

It has been proposed that lesions of the ascending noradrenergic projections render animals more vulnerable to stress. In this study, the effects of partial denervation of the locus coeruleus (LC) by DSP-4 (10 mg/kg) treatment, chronic mild stress (CMS) and their combination were examined. DSP-4 was administered to rats 1 week before the onset of CMS, which was applied for 5 weeks. In the forced swimming test, the immobility time was decreased by both DSP-4 and CMS. In the open field test, the number of defecations was increased after DSP-4 treatment plus CMS. Partial LC denervation decreased the levels of noradrenaline (NA) by 34%, increased NA turnover, and decreased the density of beta-adrenoceptors in the cerebral cortex. CMS decreased the binding affinity of beta-adrenoceptors, an effect not observed in the DSP-4 treated animals. In conclusion, 6 weeks after partial LC denervation NA turnover is increased in the cortex, and the effect of CMS on emotionality is enhanced.


Asunto(s)
Bencilaminas/toxicidad , Monoaminas Biogénicas/metabolismo , Locus Coeruleus/efectos de los fármacos , Inhibidores de la Captación de Neurotransmisores/toxicidad , Estrés Fisiológico/psicología , Análisis de Varianza , Animales , Peso Corporal/efectos de los fármacos , Enfermedad Crónica , Desnervación/métodos , Conducta Exploratoria/efectos de los fármacos , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Ratas , Ratas Wistar , Receptores Adrenérgicos/clasificación , Receptores Adrenérgicos/efectos de los fármacos , Receptores Adrenérgicos/metabolismo , Receptores de Dopamina D2/efectos de los fármacos , Receptores de Dopamina D2/metabolismo , Receptores de Serotonina/efectos de los fármacos , Receptores de Serotonina/metabolismo , Receptores de Serotonina 5-HT1 , Estrés Fisiológico/metabolismo , Sacarosa/metabolismo
7.
Psychopharmacology (Berl) ; 155(3): 251-9, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11432687

RESUMEN

RATIONALE: Social isolation of the rat from weaning influences behaviour following central noradrenaline (NA) depletion by the selective neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4). OBJECTIVES: The study characterised the effects of DSP-4 on the behaviour of isolates in the elevated plus maze and water maze. METHODS: Male Lister hooded rats were reared singly or in groups after weaning. Two weeks postweaning, the rats were injected with DSP-4 (25 mg/kg, i.p.) or saline. From week 4, rats were tested in the plus maze and in the water maze. RESULTS: DSP-4 significantly reduced cortical and hippocampal NA but had no effect on hypothalamic NA. Isolation rearing alone had no significant effects on behaviour in the elevated plus maze but enhanced retention of platform placement in the water maze as measured by increased entries to the platform annulus during the probe test. DSP-4 in group-reared rats increased activity in the open arms and increased general activity in the elevated plus maze with no effect on water maze performance. DSP-4-treated isolates spent less time in the open arms and were hypoactive in the plus maze compared to group-reared DSP-4-treated rats, and had impaired retention of spatial memory in the water maze compared to isolate controls. CONCLUSIONS: DSP-4 treatment had an 'anxiolytic' effect in group-reared rats in the elevated plus maze. In the water maze, isolation rearing enhanced retention of spatial information, an effect normalised by NA depletion. The results demonstrate the importance of noradrenergic function in the regulation of responsiveness to environmental cues.


Asunto(s)
Ansiedad/psicología , Conducta Animal/efectos de los fármacos , Bencilaminas/toxicidad , Aprendizaje por Laberinto/efectos de los fármacos , Neurotoxinas/toxicidad , Norepinefrina/fisiología , Aislamiento Social/psicología , Animales , Química Encefálica/efectos de los fármacos , Química Encefálica/fisiología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Memoria/efectos de los fármacos , Norepinefrina/metabolismo , Ratas
8.
Pharmacol Biochem Behav ; 57(1-2): 257-61, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9164580

RESUMEN

To clarify the interactions between hippocampal cholinergic and adrenergic systems in working memory function of rats, the effects of hippocampal muscarinic receptor blockade combined with noradrenaline depletion on this behavior were examined with a three-panel runway task. Intrahippocampal administration of the muscarinic receptor antagonist scopolamine at a dose of 3.2 micrograms/side significantly increased the number of errors (attempts to pass through two incorrect panels of the three panel-gates at four choice points) in the working memory task, whereas the 0.32 microgram/side dose of scopolamine did not affect working memory errors. Administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) at 50 mg/kg IP caused a marked reduction in hippocampal noradrenaline concentration, but it had no effect on working memory errors. Intrahippocampal administration of 0.32 microgram/side scopolamine, the behaviorally ineffective dose in intact rats, significantly increased the number of working memory errors in the noradrenaline-depleted animals. These results suggest that hippocampal muscarinic/noradrenergic interactions are involved in neural processes mediating working memory function of rats.


Asunto(s)
Bencilaminas/toxicidad , Hipocampo/efectos de los fármacos , Memoria a Corto Plazo/efectos de los fármacos , Antagonistas Muscarínicos/farmacología , Neurotoxinas/toxicidad , Norepinefrina/metabolismo , Animales , Dopamina/metabolismo , Evaluación Preclínica de Medicamentos , Hipocampo/metabolismo , Masculino , Microinyecciones , Ratas , Ratas Wistar , Escopolamina/farmacología , Serotonina/metabolismo
9.
Naunyn Schmiedebergs Arch Pharmacol ; 355(2): 267-72, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9050022

RESUMEN

The changes in the extracellular concentration of endogenous noradrenaline and dopamine in the frontal cortex following pretreatment with noradrenergic neurotoxin DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] were studied by in vivo microdialysis in rats anaesthetized with chloral hydrate. Noradrenaline and dopamine levels in frontal cortex were detected only when the uptake inhibitor, nomifensine (10 microM) was present in dialysis fluid. Under those conditions, the Na+ channel agonist veratridine and a depolarising concentration of potassium chloride (60 mM), applied locally through the microdialysis probe, increased the overflow of noradrenaline. Tetrodotoxin had an opposite effect. These results indicate that most of the noradrenaline probably arose from exocytotic release. Noradrenaline efflux in the frontal cortex of DSP-4 pretreated rats (52 +/- 6.1 fmol/sample) did not differ significantly from that of the control animals (69 +/- 4.9 fmol/sample). Dopamine efflux was not changed either (64 +/- 9.6 and 62 +/- 3.9 fmol/sample, respectively). The alpha 2-adrenoceptor antagonist, atipamezole (3 mg/kg i.p.), increased the overflow of noradrenaline in the frontal cortex of saline-treated rats by 100%, whereas in DSP-4 treated rats the increase was only around 30%. The overflow of dopamine was not changed under the conditions described. The effect of atipamezole in DSP-4 treated rats may be of smaller magnitude due to the diminished pool of releasable noradrenaline or due to a downregulation of presynaptic alpha 2-adrenoceptors in the frontal cortex. The perfusion of 60 mM KCl at the end of the experiment unexpectedly produced equivalent increases in noradrenaline and dopamine content in dialysates of both vehicle and DSP-4 treated rats. We conclude that the uptake inhibitor, nomifensine, and atipamezole, which had a stronger effect in vehicle-treated animals, reduced the effect of KCl-stimulation and masked the true difference in changes of noradrenaline efflux. Post-mortem tissue concentrations of noradrenaline 7 days after DSP-4 administration (50 mg/kg) were significantly reduced in the frontal cortex (54%), hippocampus (62.5%) and to lesser extent in the hypothalamus (27%) as compared to vehicle-treated rats. Dopamine and 3,4-dihydroxyphenylacetic acid concentrations were not changed confirming the efficacy and selectivity of the DSP-4 lesion. These results demonstrate that one week after DSP-4 treatment the extracellular levels of noradrenaline and dopamine as assessed by in vivo microdialysis are not changed in the frontal cortex, but atipamezole-stimulated release of noradrenaline is decreased in DSP-4 treated rats.


Asunto(s)
Bencilaminas/toxicidad , Dopamina/metabolismo , Lóbulo Frontal/efectos de los fármacos , Inhibidores de la Captación de Neurotransmisores/toxicidad , Norepinefrina/metabolismo , Antagonistas de Receptores Adrenérgicos alfa 2 , Animales , Química Encefálica/efectos de los fármacos , Lóbulo Frontal/metabolismo , Imidazoles/farmacología , Masculino , Microdiálisis , Neuronas/efectos de los fármacos , Ratas , Ratas Wistar
10.
Prog Brain Res ; 88: 257-68, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1726027

RESUMEN

There is considerable evidence from biochemical studies that the transmitter-depleting action of drugs and neurotoxins which act upon central noradrenergic (NA) axon terminals is not uniform in different brain regions. Among NA axons, those originating in the locus coeruleus (LC) have been proposed to be most susceptible to the action of NA neurotoxins such as N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4). The studies described here were conducted to determine whether this differential susceptibility to DSP-4 reflects a pharmacological heterogeneity between different populations of NA axons. To determine whether DSP-4 acts selectively upon LC axons, we have characterized the effects of this drug on NA axons in different brain regions, by using noradrenaline and dopamine-beta-hydroxylase (D beta H) immunohistochemistry. Following systemic administration of DSP-4, there was an almost complete loss of noradrenaline and D beta H staining in brain regions innervated by LC axons. No effects of the drug treatment were detected in brain regions innervated primarily by non-coerulean NA axons. These results demonstrate that both the transmitter-depleting and the neurodegenerative action of DSP-4 are restricted to NA axons originating in the LC. To explore the basis for this selectivity, noradrenaline uptake studies were conducted using synaptosomes from brain regions in which NA axons differ in their response to DSP-4. The results reveal a significant difference in the affinity of DSP-4 for the noradrenaline uptake carrier in cortical and hypothalamic synaptosomes. This finding is compatible with the hypothesis that the noradrenaline uptake carrier is pharmacologically distinct in LC and non-coerulean NA axons. This heterogeneity in noradrenaline uptake raises the question whether other drugs may also have differential actions on LC and non-coerulean NA neurons.


Asunto(s)
Adrenérgicos/farmacología , Fibras Adrenérgicas/efectos de los fármacos , Bencilaminas/farmacología , Locus Coeruleus/efectos de los fármacos , Inhibidores de la Captación de Neurotransmisores/farmacología , Norepinefrina/fisiología , Adrenérgicos/toxicidad , Axones/efectos de los fármacos , Bencilaminas/toxicidad , Corteza Cerebral/citología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Dopamina beta-Hidroxilasa/análisis , Resistencia a Medicamentos , Hipotálamo/citología , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Degeneración Nerviosa/efectos de los fármacos , Inhibidores de la Captación de Neurotransmisores/toxicidad , Oxidopamina/toxicidad , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo
11.
Eur J Pharmacol ; 141(1): 135-8, 1987 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-3117577

RESUMEN

The neurotoxin, DSP-4, (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride) specifically and significantly reduces norepinephrine (NE) and its metabolite, 3-methoxy-4-hydroxyphenylethylene glycol (MHPG), in cortical, hippocampal and cerebellar brain regions. Pretreatment with the selective monoamine oxidase (MAO) B inhibitor, deprenyl, and the non-specific MAO inhibitor, pargyline, effectively blocked NE depletion. Pretreatment with the selective MAO A inhibitor, clorgyline, had no effect on central NE DSP-4 toxicity. Thus formation of a toxic metabolite by the action of MAO B may be involved in DSP-4 induced neural damage.


Asunto(s)
Bencilaminas/antagonistas & inhibidores , Inhibidores de la Monoaminooxidasa/farmacología , Neurotoxinas/antagonistas & inhibidores , Animales , Bencilaminas/toxicidad , Química Encefálica/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Metoxihidroxifenilglicol/metabolismo , Ratones , Neurotoxinas/toxicidad , Norepinefrina/metabolismo , Pargilina/farmacología , Selegilina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA